Free PDF: The Genius Workout — 50 brain teasers + the 25 highest IQs in history.
博客

Frances Oldham Kelsey:传记、成就与不朽的遗产

Frances Kathleen Oldham Kelsey (née Oldham; July 24, 1914 – August 7, 2015) was a Canadian-American pharmacologist and physician who had a 45-year career with the U.S. Food and Drug Administration (FDA). As a reviewer, she refused to authorize thalidomide for market because she had concerns about the lack of evidence regarding the drug's safety. Her concerns proved to be justified when it was shown that thalidomide caused serious birth defects. Kelsey's career intersected with the passage of laws strengthening FDA oversight of pharmaceuticals. Kelsey was the first woman to receive a PhD in pharmacology and the second woman to receive the President's Award for Distinguished Federal Civilian Service, awarded to her by John F. Kennedy in 1962.

关键事实

遗产与影响

The influence of Frances Oldham Kelsey extends far beyond her own lifetime. She fundamentally shaped healthcare and human longevity, and her medical discoveries and treatments remain foundational to this day.

Though she passed away in 2015, her ideas continue to be studied, debated, and built upon by scholars and practitioners worldwide.

Frances Oldham Kelsey至今仍是Canada诞生的最受赞誉的头脑之一,是该地区丰厚思想遗产的明证。

Canada的杰出天才

Canada孕育了众多卓越的头脑。与Frances Oldham Kelsey并列:

查看Canada的所有天才 →

探索Medicine领域更多杰出头脑

探索 Medicine Geniuses

探索更多

阅读Frances Oldham Kelsey的完整资料

查看Frances Oldham Kelsey的资料 →

探索更多天才

1,300+ articles · 1,300+ biographies · 中文

查看全部